Su Su1, Atsushi Watanabe, Motoko Yamamoto
1Department of Biochemistry and Molecular Biology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan.
Retroviral vectors used in gene therapy can cause mutations. While p53 gene therapy showed high mutation rates in resistant cancer cells, further analysis revealed low p53 mutation rates, indicating retroviral replication errors pose a significant risk.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: